HIV-1 integrase inhibitors: a comparative review of efficacy and safety

KK Scarsi, JP Havens, AT Podany, SN Avedissian… - Drugs, 2020 - Springer
The newest class of antiretrovirals for all persons living with HIV are the integrase strand
transfer inhibitors (INSTIs). Since 2007, five INSTIs have been introduced: raltegravir …

Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis

S Kanters, M Vitoria, M Doherty, ME Socias, N Ford… - The lancet HIV, 2016 - thelancet.com
Background New antiretroviral therapy (ART) regimens for HIV could improve clinical
outcomes for patients. To inform global guidelines, we aimed to assess the comparative …

Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …

P Nahid, SE Dorman, N Alipanah… - Clinical infectious …, 2016 - academic.oup.com
Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel

HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron… - Jama, 2016 - jamanetwork.com
Importance New data and therapeutic options warrant updated recommendations for the use
of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …

Adult antiretroviral therapy guidelines 2017

G Meintjes, MA Moorhouse, S Carmona… - … African journal of HIV …, 2017 - journals.co.za
These guidelines are intended as an update to those published in the Southern African
Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in …

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel

HF Günthard, JA Aberg, JJ Eron, JF Hoy, A Telenti… - Jama, 2014 - jamanetwork.com
Importance New data and antiretroviral regimens expand treatment choices in resource-rich
settings and warrant an update of recommendations to treat adults infected with human …

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled …

R Griesel, Y Zhao, B Simmons, Z Omar, L Wiesner… - The Lancet …, 2023 - thelancet.com
Background The drug–drug interaction between rifampicin and dolutegravir can be
overcome by supplemental dolutegravir dosing, which is difficult to implement in high …

Dolutegravir-based antiretroviral therapy for patients coinfected with tuberculosis and human immunodeficiency virus: a multicenter, noncomparative, open-label …

KE Dooley, R Kaplan, N Mwelase… - Clinical Infectious …, 2020 - academic.oup.com
Background The concurrent treatment of tuberculosis and human immunodeficiency virus
(HIV) is challenging, owing to drug interactions, overlapping toxicities, and immune …

S2k-Leitlinie: Tuberkulose im Erwachsenenalter

T Schaberg, T Bauer, F Brinkmann, R Diel… - …, 2017 - thieme-connect.com
In Deutschland ist seit 2015 ein deutlicher Anstieg der gemeldeten Tuberkulosefälle zu
verzeichnen. Zurückzuführen ist dieser vor allem auf die aktuell vermehrte Migration. Durch …

Global HIV neurology: a comprehensive review

KT Thakur, A Boubour, D Saylor, M Das, DR Bearden… - Aids, 2019 - journals.lww.com
Neurological conditions associated with HIV remain major contributors to morbidity and
mortality and are increasingly recognized in the aging population on long-standing …